Inhibition of Autophagy Enhances the Effects of E1A-Defective Oncolytic Adenovirus dl922–947 Against Glioma Cells In Vitro and In Vivo-Reference-Cited by-同舟云学术

Inhibition of Autophagy Enhances the Effects of E1A-Defective Oncolytic Adenovirus dl922–947 Against Glioma Cells In Vitro and In Vivo

Published:2012-06 Issue:6 Volume:23 Page:623-634
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Botta Ginevra¹,Passaro Carmela¹,Libertini Silvana¹,Abagnale Antonella¹,Barbato Sara¹,Maione Angela Serena¹,Hallden Gunnel²,Beguinot Francesco¹,Formisano Pietro¹,Portella Giuseppe¹

Affiliation:

1. Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università Federico II, 80131, Naples, Italy.

2. Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, EC1M 6BQ, London, United Kingdom.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2011.120

Reference52 articles.

1. Long-term outcome and survival of surgically treated supratentorial low-grade glioma in adult patients

2. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma

3. Autophagy: dual roles in life and death?

4. Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer

5. Phosphorylation of Ribosomal Protein S6 Is Inhibitory for Autophagy in Isolated Rat Hepatocytes

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing cancer treatment: the power of bi- and tri-specific T-cell engagers in oncolytic virotherapy;Frontiers in Immunology;2024-02-22

2. Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response;Frontiers in Cellular and Infection Microbiology;2023-03-15

3. Combination of dl922-947 Oncolytic Adenovirus and G-Quadruplex Binders Uncovers Improved Antitumor Activity in Breast Cancer;Cells;2022-08-10

4. Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy;Cancers;2022-07-29

5. Inhibition of MEK-ERK pathway enhances oncolytic vaccinia virus replication in doxorubicin-resistant ovarian cancer;Molecular Therapy - Oncolytics;2022-06